Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.
PR Newswire, 810 Seventh Avenue, New York, NY 10019 - Tuesday October 21 8:15 AM EDT
Medizone President and Chief Operating Officer, Milton G. Adair and the Company's Director of Research and Development, Gerard V. Sunnen, M.D., will travel to Italy the week of November 10, 1997 to finalize the details of the agreements with Dr. Mariano Franzini, Professor at the Universita of Pavia and President of the Italian Scientific Society for Oxygen-Ozone Therapy ("ISSOT") who, as required by law, acts as an on-site coordinator. They will also meet with study site coordinators, Drs. Carlo Giaquinto and Umberto Tirelli. Dr. Giaquinto is a Professor at the Departimento of Pediatria, Universita di Padova, Padova, Italy, and Project Leader of the Pediatric AIDS Clinical Trial Group at Padova Universita Hospital. Dr. Tirelli serves as Chief, Division of Oncology and AIDS at the National Cancer Center, Aviano, Italy.
Once the final agreements are signed and the protocols approved, patient enrollment will begin. It is anticipated that the trials will commence during the first quarter of 1998.
Medizone's Chairman of the Board, Edwin Marshall stated, "I'm extremely pleased with the energy and focus of our new management team. Moving forward with our research efforts is clearly the best use of our financial resources while providing us the opportunity to validate the patented Medizone "thin- film" technology."
Medizone International, Inc., is a research and development stage company engaged in the development of an ozone-based treatment for diseases caused by lipid enveloped viruses, including Acquired Immune Deficiency Syndrome (AIDS), Hepatitis B and Herpes; and in the development of its patented technology for the decontamination of blood and blood products. For information call CTC, Inc., 937-434-2700 or Medizone International, Inc., 801-274-8400 or visit the company's website at www.medizoneint.com.
This press release contains certain forward-looking statements about the Company's goals and anticipated future performance. The industry in which the Company proposes to operate is dynamic and intensely competitive and there are many factors that could cause the forward-looking statements contained herein not to occur or the timing of their occurrence to be delayed. With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products and competitive environment, availability of raw materials and critical manufacturing equipment and facilities and other risks identified in filings made with the Securities and Exchange Commission.
SOURCE Medizone International, Inc. Copyright (c) 1997/PR NewsWire. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Permissions Desk, PR Newswire, 810 Seventh Avenue, New York, NY 10019.
971021
PR971013
Copyright © 1997 - PRNewswire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through PRNewswire, Permissions, 810 Seventh Ave., 32nd Floor, New York, NY 10019 http://www.prnewswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.
Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .